Search results
The Patient Assistance Program provides medication at no cost to those who qualify. Patients who are approved for the PAP may qualify to receive free medicine from Novo Nordisk. There is no registration charge or monthly fee for participating. Click here for a list of our Novo Nordisk products covered by the PAP.
Apr 20, 2024 · For most of its 100 years Novo Nordisk has been focused on the steady business of treating diabetes, one of the world’s most prevalent chronic diseases. Even today, it produces half the world’s...
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in discovering and developing treatment for serious chronic disease, like diabetes and obesity.
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland...
Novo Nordisk was named as the Best Place in the World to Work in 2022, but our people are what make our company what it is today, and will continue to shape our future. Discovering novel therapies to treat chronic disease for over 100 years. Learn who we are.
May 2, 2024 · Current and previous financial results, including annual reports, quarterly company announcements, investor presentations, financial workbooks, investor calls and webcasts. 2024. 2023.
What We Do | Novo Nordisk U.S. Facts and figures. 50% amount of the world’s insulin supply we produce. 40m+. people using our diabetes care products. 800m+. number of insulin pens we produced. 40+. countries where we conduct clinical trials. Treating four therapeutic areas.
